“We need faster, more reliable and cost-effective diagnostic systems and data management tools that accelerate health decisions and facilitate patient treatment.”
The breakthroughs of the ZURETZAT initiative to increase the competitiveness of the Basque industrial fabric in the diagnostic sector
TECNALIA is working on the ZURETZAT initiative to research and develop new diagnostic platforms and new products related to different platforms: sensor systems, reading devices and data management tools.
The combination of medical knowledge, technology and data science is revolutionising medicine, giving way to personalised health. Detection, diagnosis, treatment and even disease prevention transform people’s lives more quickly and effectively, guaranteeing appropriate and individualised treatment for each patient.
Diagnosis for detection and overall improvement of health
ZURETZAT is an industrial initiative supported by the Department of Economic Development, Sustainability and Environment of the Basque Government. It falls within the Personalised Health strategic priority, set out in the bases of the RIS3 Euskadi 2030 smart specialisation strategy.
The project focuses specifically on the field of diagnostics for comprehensive health detection and improvement by applying cloud platforms and artificial intelligence: it offers personalised diagnoses that improve the treatments of diseases and therefore the quality of life, delaying ageing.
The opportunity that the ZURETZAT project offers the Basque Country lies in the growth of the diagnostic industry, positioning Basque companies in the sector (mostly SMEs), making them grow and attracting new ones to complete the value chain of these products.
TECNALIA is a benchmark research and technological development centre in Europe and part of the Basque Research and Technology Alliance (BRTA), with 1,400 professionals of 30 nationalities, focused on transforming technology into GDP to improve people’s quality of life, thereby creating business opportunities for companies. Its main areas of activity are: Health, Digital Transformation, Advanced Manufacturing, Energy Transition, Sustainable Mobility and Urban Ecosystem.
The company develops personalised products and services in the stages of prevention, diagnosis, prognosis, treatment and rehabilitation, through a comprehensive approach that includes genetics, nutrition and the physical and social environment, the main variables that affect people’s health. In particular, it works in the fields of healthy eating, neuroengineering, biomaterials, medical robotics, digital health, in vitro diagnosis, medical imaging and pharmaceutical development.